EC reveals plans for unitary SPC, compulsory licences

The European Commission will unveil plans to make supplementary protection certificates (SPC) more accessible and efficient for pharmaceutical companies to register and enforce by the end of March.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

European Commission's first deal for COVID-19 vaccine takes effect

1 September 2020 The European Commission’s first ever contract to secure a COVID-19 vaccine came into force on August 27, after it signed a deal with pharmaceutical company AstraZeneca.

Big Pharma

European Commission commits €100bn for research and innovation

8 June 2018 The European Commission has proposed that the next long-term EU budget (2021-2027) includes €100 billion ($117.55 billion) for research and innovation, in what it calls the most ambitious such programme yet.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Former PTAB judge joins Sterne Kessler

EC reveals plans for unitary SPC, compulsory licences

More on this story

Editor's picks

Editor's picks

More features